Changing epidemiology, global trends and implications for outcomes of NAFLD.

By V. Wai‐Sun Wong, M. Ekstedt, Grace Lai-Hung Wong, H. Hagström. Journal of Hepatology, 2023

632 citations recorded by the source corpus.

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver disease globally, currently estimated to affect 38% of the global population. A minority of patients with NAFLD will progress to cirrhosis or hepatocellular carcinoma, but the total number of this vast population that risk such severe outcomes is increasing. Worryingly, persons are affected by NAFLD at an earlier age, suggesting they have longer time to develop severe complications. With considerable changes in diet composition and urbanization, obesity and type 2 diabetes among the global population, in particular in developing countries, the global proportion of persons affected by NAFLD is projected to be further increasing. Yet, there are large geographical discrepancies in the prevalence rates of NAFLD and its inflammatory component non-alcoholic steatohepatitis (NASH). Such differences are partly related to differing socio-economic milieus, but also to genetic predisposition. This narrative review discusses recent changes in the epidemiology of NAFLD and NASH from regional and global perspectives, as well as in special populations. We also discuss the consequences these changes can have on hepatic and extra-hepatic events.

Subfields: Epidemiology, Hepatology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/e54c77ef9d80515918511aa210a18579c868500c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

  1. Z. Younossi

In Hepatology

  1. Z. Younossi

In Pathology and Forensic Medicine

  1. Z. Younossi

Citations in the corpus